Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company has two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEFâ„¢, a unique, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain. ( www.ymbiosciences.com )
YM BioSciences Inc.
Suite 400 Building 11 5045 Orbitor Drive
Mississauga, Ontario L4W 4Y4
Canada
Tel: (905) 629-9761
Fax: (905) 629-4959